QQ客服 官方微博 反馈留言

	Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer
	Xiang, Quping[1,2]; Zhang, Yan[1,2]; Li, Jiaguo[1,3]; Xue, Xiaoqian[1,2]; Wang, Chao[1]; Song, Ming[1]; Zhang, Cheng[1,3]; Wang, Rui[1]; Li, Chenchang[1,3]; Wu, Chun[1]
	2018
卷号	9期号:3页码:262
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4433591
专题	暨南大学
作者单位	1.[1]Guangzhou Med Univ, Chinese Acad Sci, Guangdong Prov Key Lab Biocomp, Joint Sch Life Sci,Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China 2.[2]Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 3.[3]Jilin Univ, Sch Pharmaceut Sci, 1266 Fujin Rd, Changchun 130021, Jilin, Peoples R China 4.[4]Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China 5.[5]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Xiang, Quping[1,2],Zhang, Yan[1,2],Li, Jiaguo[1,3],et al. Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer[J],2018,9(3):262.
APA	Xiang, Quping[1,2].,Zhang, Yan[1,2].,Li, Jiaguo[1,3].,Xue, Xiaoqian[1,2].,Wang, Chao[1].,...&Xu, Yong[1].(2018).Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer.,9(3),262.
MLA	Xiang, Quping[1,2],et al."Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer".9.3(2018):262.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。